Hospital admissions for chronic obstructive pulmonary disease in New Zealand

New Zealand Medical Journal

Volumn 128, Issue 1408, 2015, Pages 23-35

  Milne, Richard J ^a   Beasley, Richard ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSIS RELATED GROUP; ETHINICITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; MORBIDITY; PATIENT COMPLICATION; SOCIOECONOMICS; AGE DISTRIBUTION; ECONOMICS; ETHNOLOGY; HEALTH CARE COST; HOSPITAL READMISSION; HOSPITALIZATION; NEW ZEALAND; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SOCIAL CLASS; TRENDS; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NEW ZEALAND; PATIENT READMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SOCIAL CLASS;

EID: 84930278830     PISSN: 00288446     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. MOH. Mortality and Demographic Data 2009. Wellington2014; Available from: http://www.health.govt.nz/publication/mortality-and-demographic-data-2009
2. Davis P, Lay-Yee R, Fitzjohn J, et al. Co-morbidity and health outcomes in three Auckland hospitals. N Z Med J. 2002;115(1153):211-5.
3. Robson B, Harris R. Hauora: Maori Standards of Health IV. A study of the years 2000-2005. Wellington: Te Ropu Rangahau Hauora a Eru Pomare. 2007; Available from: http://www.otago.ac.nz/wellington/research/erupomare/projects/otago019494.html
4. OECD. OECD Library. 2011; Available from: http://www.oecd-ilibrary.org/.
5. MOH. NZdep2013 index of deprivation. 2014; Available from: http://www.health.govt.nz/publication/nzdep2013-index-deprivation
6. MOH. National minimum Data (Hospital Admissions). 2014; Available from: http://www.health.govt.nz/publication/national-minimum-dataset-hospital-events-data-mart-datadictionary
7. WHO. Age standardization of rates: a new WHO standard. 2001; Available from: http://www.who.int/healthinfo/paper31.pdf
8. MOH. Publicly funded hospital discharges in FY2011/12. 2013; Available from: http://www.health.govt.nz/publication/publicly-funded-hospital-discharges-1-july-2011-30-june-2012
9. Chang CL, Sullivan GD, Karalus NC, et al. Audit of acute admissions of chronic obstructive pulmonary disease: inpatient management and outcome. Intern Med J. 2007;37(4):236-41.
10. Broad J, Jackson R. Chronic obstructive pulmonary disease and lung cancer in New Zealand. Report prepared for the Thoracic Society of Australia and New Zealand. Auckland: University of Auckland, Uniservices; 2003.
11. Glover M, Kira A, Cowie N, et al. Health consequences of tobacco use for Maori—cessation essential for reducing inequalities in health. N Z Med J. 2013;126(1379):60-73.
12. Bramley D, Hebert P, Tuzzio L, Chassin M. Disparities in indigenous health: a cross-country comparison between New Zealand and the United States. Am J Public Health. 2005;95(5):844-50.
13. Feemster LC, Au DH. Penalizing hospitals for chronic obstructive pulmonary disease readmissions. Am J Respir Crit Care Med. 2014;189(6):634-9.
14. Nguyen HQ, Chu L, Amy Liu I-L, et al. Associations between physical activity and 30-day readmission risk in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(5):695-705.
15. Sharif R, Parekh TM, Pierson KS, et al. Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(5):685-94.
16. Wilkinson T, North M, Bourne SC. Reducing hospital admissions and improving the diagnosis of COPD in Southampton City: methods and results of a 12-month service improvement project. NPJ Prim Care Respir Med. 2014;24:14035.
17. Fieldston ES, Ragavan M, Jayaraman B, et al. Scheduled admissions and high occupancy at achildren's hospital. J Hosp Med. 2011;6(2):81-7.
18. Forastiere F, Mallone S, Lo Presti E, et al. Characteristics of nonsmoking women exposed to spouses who smoke: epidemiologic study on environment and health in women from four Italian areas. Environ Health Perspect. 2000;108(12):1171-7.
19. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol. 2000;53(7):755-61.
20. Donaldson GC, Goldring JJ, Wedzicha JA. Influence of season on exacerbation characteristics in patients with COPD. Chest. 2012;141(1):94-100.
21. Kurai D, Saraya T, Ishii H, Takizawa H. Virus-induced exacerbations in asthma and COPD. Front Microbiol. 2013;4:293.
22. Viggers H, Howden-Chapman P, Ingham T, et al. Warm homes for older people: aims and methods of a randomised community-based trial for people with COPD. BMC Public Health. 2013;13:176.
23. Harre ES, Price PD, Ayrey RB, et al. Respiratory effects of air pollution in chronic obstructive pulmonary disease: a three month prospective study. Thorax. 1997;52(12):1040-4.
24. Milne B. Ambulatory sensitive hospitalisations in New Zealand, 2001-2009. 2013; Available from: http://www.arts.auckland.ac.nz/en/about/ourresearch-1/research-centres-and-archives/centre-ofmethods-and-policy-application-in-the-social-sciences-compass/compass-annual-researchcolloquiums.html
25. Dalal AA, Christensen L, Liu F, Riedel AA. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis. 2010;5:341-9.
26. Simon-Tuval T, Scharf SM, Maimon N, et al. Determinants of elevated healthcare utilization in patients with COPD. Respir Res. 2011;12:7.
27. Mapel DW, Schum M, Lydick E, Marton JP. A new method for examining the cost savings of reducing COPD exacerbations. Pharmacoeconomics. 2010;28(9):733-49.
28. Anon. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2014. 2014.
29. Rea H, McAuley S, Stewart A, et al. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J. 2004;34(11):608-14.
30. Milne RJ, Hockey H, Rea H. Long-term air humidification therapy is cost effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasis. Value Health. 2014;17:320-7.
31. Rea H, McAuley S, Jayaram L, et al. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med. 2010;104(4):525-33.